Metropolis Healthcare Limited (NSE:METROPOLIS)
1,939.30
-17.30 (-0.88%)
At close: Dec 2, 2025
Metropolis Healthcare Revenue
Metropolis Healthcare had revenue of 4.29B INR in the quarter ending September 30, 2025, with 22.70% growth. This brings the company's revenue in the last twelve months to 14.83B, up 15.41% year-over-year. In the fiscal year ending March 31, 2025, Metropolis Healthcare had annual revenue of 13.31B with 10.23% growth.
Revenue (ttm)
14.83B
Revenue Growth
+15.41%
P/S Ratio
6.78
Revenue / Employee
3.08M
Employees
4,823
Market Cap
100.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 13.31B | 1.23B | 10.23% |
| Mar 31, 2024 | 12.08B | 594.99M | 5.18% |
| Mar 31, 2023 | 11.48B | -801.26M | -6.52% |
| Mar 31, 2022 | 12.28B | 2.30B | 23.08% |
| Mar 31, 2021 | 9.98B | 1.42B | 16.53% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Aurobindo Pharma | 325.14B |
| Cipla | 279.66B |
| Zydus Lifesciences | 244.94B |
| Apollo Hospitals Enterprise | 232.65B |
| Glenmark Pharmaceuticals | 159.97B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |
Metropolis Healthcare News
- 15 days ago - Metropolis Healthcare Ltd (BOM:542650) Q2 2026 Earnings Call Highlights: Strong Revenue Growth ... - GuruFocus
- 15 days ago - Q2 2026 Metropolis Healthcare Ltd Earnings Call Transcript - GuruFocus
- 26 days ago - Metropolis Healthcare shares jump over 3% as Q2 revenue rises 22.7% YoY to Rs 429 crore, net profit up 13.2% - Business Upturn
- 27 days ago - What To Expect From Metropolis Healthcare Ltd (BOM:542650) Q2 2026 Earnings - GuruFocus
- 2 months ago - Metropolis Healthcare incorporates new subsidiary Metropolis Quality Solutions - Business Upturn
- 4 months ago - Metropolis Healthcare shares jump nearly 3% following Q1 results; Company projects over 12% revenue growth in FY26 - Business Upturn
- 5 months ago - Metropolis Healthcare eyes double-digit growth as B2C gains traction - Business Upturn
- 5 months ago - Metropolis Healthcare shares rise over 2% today as specialty and TruHealth segments post strong Q1 growth - Business Upturn